Top 50 Digital Therapeutics in Asia

Nunaps is a digital therapeutics startup focused on developing evidence-based interventions for mental health conditions through mobile applications. The platform provides users with personalized treatment plans and real-time progress tracking, enhancing accessibility to mental health care.

Hippo TC develops digital therapeutics that employ evidence-based algorithms for diagnosing and treating depression, diabetes, and skin diseases. Their platform delivers personalized treatment plans and real-time monitoring, enhancing patient adherence and improving health outcomes.

Fitterfly provides personalized digital therapeutics programs for diabetes management and weight loss, utilizing continuous glucose monitoring and data-driven lifestyle interventions. Their approach combines expert guidance in nutrition, exercise, and mental wellness to help users achieve measurable health improvements, such as an average HbA1c reduction of 1.96% and weight loss of 5 kg.

Wundrsight is developing a Mixed Reality AI-based digital therapeutics platform that utilizes medical-grade virtual reality to deliver immersive therapy for various mental health conditions, enhancing patient engagement and treatment outcomes. The platform addresses the shortage of clinicians in India by providing scalable, medication-free interventions that achieve over 80% adherence and significant symptom remission.

Zeen Health is a digital therapeutics company that utilizes evidence-based cognitive behavioral therapy (CBT) techniques to provide accessible mental health services. The platform addresses the growing demand for effective mental health support by offering personalized treatment plans that improve user engagement and outcomes.

The startup develops wearable therapeutic devices that enable therapists, acupuncturists, and caregivers to maintain real-time connectivity with patients through digital data sharing. This technology facilitates e-therapy prescriptions, helping patients lower healthcare costs and minimize the frequency of outpatient and hospital visits.

WELT develops digital biomarkers and digital therapeutics that utilize smartphone and sensor data to monitor and predict health outcomes. The platform delivers personalized therapies to manage and prevent diseases, addressing the need for effective, data-driven healthcare solutions.

The startup develops artificial intelligence-driven digital therapeutics specifically designed for the management of neuropsychological disorders. Their technology enables healthcare professionals to enhance treatment efficacy and patient outcomes through tailored therapeutic interventions.

Prognoix develops evidence-based digital medicine solutions to address stigmatized health conditions. The company offers prescription digital therapeutics (DTx) like Melonga for premature ejaculation, providing discreet care access. Future pipeline products target metabolic syndrome and specific women's health issues.

Remepy develops Hybrid Drugs that combine pharmaceutical molecules with AI-driven digital protocols to improve clinical outcomes. These therapies integrate traditional medication with app-delivered digital interventions targeting motor, cognitive, and mental functions. The company leverages a Drug-SaMD combination pathway to validate and approve these novel, personalized treatment modalities.

Neuroglee Therapeutics offers a digital therapeutic platform that provides personalized, multi-domain care plans and cognitive training for patients with mild cognitive impairment and dementia. By integrating a physician-led virtual care team and ongoing assessments, the platform enhances patient outcomes and supports caregivers in managing brain health from home.

Wangli Technology is a digital therapy platform that utilizes evidence-based cognitive behavioral therapy (CBT) techniques to provide accessible mental health support. The platform addresses the growing need for effective mental health interventions by offering personalized therapy sessions that can be accessed remotely, improving patient engagement and outcomes.

eMotiv develops a mobile application that utilizes cognitive assessment through interactive games to evaluate mental health conditions, including ADHD. This platform provides users with accessible and engaging digital therapeutics aimed at enhancing cognitive function and improving overall mental well-being.

Zyla Health is an AI-driven healthcare management platform that utilizes a proprietary medical AI engine to deliver personalized lifestyle interventions, including nutrition and exercise, aimed at improving health outcomes for patients with chronic conditions like diabetes and heart disease. By providing continuous, data-informed care, Zyla Health enhances patient engagement and reduces healthcare costs for individuals and organizations.

Meru Health provides a digital mental health platform that combines personalized therapy sessions with evidence-based practices, including daily mindfulness exercises and biofeedback tools. The service addresses anxiety and depression by offering continuous support through licensed therapists and a secure chat feature, resulting in significant improvements in emotional well-being within 12 weeks.

PainPal is a telebehavioral health platform that offers personalized, gamified behavioral and cognitive counseling through an on-demand digital interface. It addresses the need for accessible mental health support by providing users with immediate, tailored therapeutic interventions.

Silvia is an age-tech platform that provides a digital treatment device for patients with mild cognitive impairment (MCI), utilizing software to enhance cognitive function and slow the progression to dementia. The platform also offers easy-to-use screening tools for early detection of cognitive decline, aimed at reducing the risk of degenerative brain diseases in middle-aged and elderly individuals.

Naluri is a digital health platform that utilizes predictive analytics and structured care programs to manage cardiometabolic and mental health conditions among employees. By providing targeted strategies for chronic disease management and mental wellness, Naluri enhances employee health outcomes and reduces healthcare costs for organizations.

Betteryou is an AI-assisted psychotherapy platform that utilizes real-time biofeedback and automated clinical documentation to enhance online therapy sessions. It provides continuous support and personalized care by automating regular checkups and integrating memory work through generative AI, improving patient engagement and therapeutic outcomes.

The startup offers a B2B2C digital mental therapy platform that utilizes real-time counselor matching and both online and offline counseling options to enhance access to mental health support. It addresses the lack of affordable and timely mental health care by providing a confidential space for users to discuss personal, relationship, financial, and career-related issues.

The startup offers a digital health platform that connects patients with a network of mental health professionals to deliver personalized, evidence-based mental health programs and therapies. This system provides users with tailored self-help resources and consultations, addressing the need for accessible and individualized mental health support.

Mobio Interactive offers a remote patient monitoring platform that utilizes facial photoplethysmography and deep neural networks to objectively assess therapy effectiveness in mental health treatment. This technology enables personalized interventions that have been clinically validated to reduce anxiety, depression, and stress across diverse patient populations.

This startup provides real-time monitoring of cognitive and emotional states through wearable devices, enabling users to gain insights into their mental health. By offering personalized mental healthcare solutions, the company addresses the need for accessible mental health support for individuals everywhere.

Mindvivo is an AI-driven mental health platform that provides a secure environment for users to access community support and mental wellness resources. It addresses the need for accessible mental health care by connecting individuals with tailored tools and peer support to enhance their emotional well-being.

Eleven Therapeutics utilizes synthetic chemistry and AI algorithms to develop RNA therapeutics that optimize safety, efficiency, and duration of effect. Their platform maps the vast chemical space of RNA molecules, addressing the need for precise and effective therapeutic solutions in the rapidly evolving field of RNA-based medicine.

The startup develops diagnostic and therapeutic devices that utilize neurofeedback technology based on brain circuit markers to identify mental illnesses. This approach enables healthcare providers to deliver targeted treatments, improving patient outcomes in mental health care.

This healthcare company offers a digital platform for chronic disease management, integrating voice analysis, telemedicine, symptom tracking, and AI-assisted rehabilitation. The platform aims to improve patient outcomes and quality of life by providing comprehensive tools for managing chronic conditions.

Signet Therapeutics develops targeted therapeutics that employ precision medicine techniques to identify and inhibit specific pathways in cancer cells. The company provides personalized treatment options for patients with various cancer types, addressing the limitations of traditional therapies.

SK Therapeutics is an AI-driven platform that accelerates drug development by utilizing machine learning algorithms to identify potential drug candidates and optimize their efficacy. This approach addresses the lengthy and costly traditional drug discovery process, significantly reducing time-to-market for new therapeutics.

This startup offers a mobile application that utilizes artificial intelligence and machine learning to enhance mental wellness through personalized support and resources. It addresses the growing need for accessible mental health tools by providing users with tailored strategies and insights to improve their emotional well-being.

Awarefy develops cognitive behavioral therapy (CBT) applications designed to enhance mental well-being by providing users with structured therapeutic exercises and real-time mood tracking. The platform addresses the growing need for accessible mental health resources, enabling individuals to manage anxiety and depression effectively.

The startup offers a health guidance platform that provides remote-specific health services focused on lifestyle-related diseases through digital health technologies. By enabling patients and medical professionals to collaborate, the platform aims to improve health outcomes and promote preventive care globally.

The startup develops digital examination devices that utilize AI-based emotion recognition and neurostimulation technology to provide objective data for psychiatric treatment and diagnosis. This technology enables practitioners to enhance diagnostic accuracy and treatment efficacy in mental health care.

Primanova develops a digital platform that enhances neurological care by facilitating real-time communication and data sharing between physicians and patients. This approach improves patient outcomes by providing personalized treatment plans and continuous monitoring of neurological conditions.

The startup develops digital healthcare solutions focused on muscle health, utilizing data analytics and telehealth platforms to provide targeted treatments for muscle-related conditions. By enabling healthcare providers and patients to access specialized products and services, the company aims to reduce the incidence of major diseases linked to muscle deterioration.

Aktivo Labs provides a real-time digital health platform that utilizes a risk analytics engine and personalized health guides to empower enterprises and governments in managing chronic disease prevention. By leveraging over 9 million years of patient data and 8,300 unique health parameters, the platform enables scalable, evidence-based health solutions that reduce the risk of common chronic diseases by an average of 25%.

The startup operates an artificial intelligence-driven digital health platform that includes a continuous monitoring device for knee joints, providing real-time musculoskeletal assessments and exercise guidance. This technology aims to reduce the burden of musculoskeletal conditions by enabling pre-consultation assessments and personalized therapy for patients.

Develops programmable oligonucleotide therapeutics that autonomously silence disease-causing RNAs in human and pathogen cells. This platform targets genetically driven diseases, chronic conditions, and multidrug-resistant infections, offering safer and more precise treatments for conditions like cancer, ALS, and MRSA.

The startup develops RNA-based therapeutics targeting unmet clinical needs in infectious diseases, tumor immunology, and metabolic disorders. Their research pipeline focuses on creating effective vaccines and treatments that enhance patient outcomes in these critical health areas.

Neurowyzr provides digital brain health measurement tools that utilize advanced analytics and AI for the early detection and monitoring of cognitive decline. By offering objective and accessible assessments, the platform helps individuals identify potential brain health issues before they lead to serious conditions like dementia or Alzheimer's disease.

BiPSEE develops next-generation mental healthcare solutions by integrating Virtual Reality (VR) and Artificial Intelligence (AI) technologies. This platform aims to provide novel forms of psychological care and medical treatment delivery. The company focuses on leveraging these advanced technologies to enhance accessibility and efficacy in mental health services.

Beyond Therapeutics utilizes its ExCEED technology to accelerate the discovery and development of new medications targeting unmet therapeutic needs. This platform enhances the efficiency of drug development processes, reducing time-to-market for critical treatments.

Maya is an online mental health service in India that provides personalized therapy tailored to individual strengths and challenges. The platform enhances accessibility to quality mental health care, addressing the need for ongoing mental health support rather than just crisis intervention.

Nanocarry develops therapeutics designed to deliver biologics across the Blood-Brain Barrier (BBB) for treating brain cancers and CNS diseases. Their proprietary AXS technology platform enables significantly increased brain delivery of therapeutic antibodies using a Plug & Play approach. This platform facilitates the creation of novel biologics to address neurological conditions currently excluded by existing treatments.

This healthcare platform provides personalized chronic pain management through a multidisciplinary approach, offering convenient and accessible care. By addressing the biological, psychological, and social aspects of pain, the platform delivers comprehensive solutions for individuals seeking relief.

NidraAI uses personalized neuroalgorithms and FDA-certified technology to help users achieve deep, restorative sleep. Their platform aims to reprogram the brain for improved sleep, addressing issues like anxiety and burnout linked to sleep deprivation.

The startup has developed a digital therapeutic platform that utilizes artificial intelligence and offline speaker services to enhance cognitive function in individuals with cognitive impairment. This technology provides medical professionals with software-based cognitive training regimens and diagnostic tools specifically designed for dementia treatment.

The startup offers an online healthcare platform that integrates meditation, counseling, and mood and sleep cycle tracking to enhance mental wellness. By connecting users with licensed psychologists, the platform provides accessible mental health services to individuals seeking support.

The startup operates a well-being platform that integrates modern psychiatric services with Islamic principles derived from the Quran and Sunnah. It provides users with mindfulness applications and self-care tools to manage mental health and alleviate stress effectively.

The startup develops digital therapeutics and health applications that provide targeted treatment methods for complex diseases such as ophthalmology, neuropsychiatry, cancer, and immunology. By leveraging therapeutic devices and technologies, the company addresses the unmet medical needs of patients who struggle to find effective treatments with existing medical solutions.